Industry Overview
Intravenous (IV) fluids are sterile solutions administered directly into the bloodstream to restore body fluids, maintain hydration, correct electrolyte imbalances, and provide calories when required. They are widely used in hospitals, nursing homes, and healthcare facilities for patients experiencing acute dehydration, hypovolemia, or other debilitating medical conditions. Among the commonly administered IV fluids are dextrose injection fluid and dextrose with sodium chloride injection fluid.
IV fluids are broadly classified into crystalloids, colloids, free water solutions, and blood products. Crystalloid solutions contain balanced salts or electrolytes and can be isotonic, hypertonic, or hypotonic depending on their composition. Common examples include normal saline, Lactated Ringer’s solution, Ringer’s solution, and hypertonic saline. Colloid solutions contain high-molecular-weight substances that remain within the intravascular space and act as plasma expanders by exerting oncotic pressure. Free water solutions, such as dextrose in water formulations, provide water and carbohydrates that can support patients during fasting while helping reduce protein breakdown. Blood products, including whole blood, packed red blood cells, plasma, cryoprecipitate, platelets, and albumin, are also used for specialized therapeutic purposes.
Intravenous fluid therapy serves three primary functions: supplying fluids, electrolytes, and calories. It is commonly used to rapidly expand intravascular volume in hypovolemic conditions, correct electrolyte disturbances, and maintain baseline hydration in patients unable to meet their fluid requirements through oral intake. Proper selection of IV fluid depends on the patient's clinical condition, therapeutic objectives, and electrolyte requirements.
Cost Estimation
| Particular | Value |
|---|---|
| Plant Capacity | 24,000 Bags/Day |
| Land & Building (5000 sq.mt.) | Rs. 2.96 Cr |
| Plant & Machinery | Rs. 5.27 Cr |
| Working Capital for 3 Months | Rs. 7.14 Cr |
| Total Capital Investment | Rs. 16.22 Cr |
| Rate of Return | 27% |
| Break Even Point | 56% |
Content Index
- INTRODUCTION
- TYPES OF IV FLUID
- COMMONLY USED IV FLUIDS
- HOW INTRAVENOUS FLUIDS ARE CREATED
- IV FLUID/ELECTROLYTE THERAPY
- KEY TERMS
- DEXTROSE
- DEXTROSE SALINE INJECTION
- PROPERTIES
- TABLE I: PHYSICAL PROPERTIES OF D-GLUCOSE
- TABLE 2: SOLUBILITY OF DEXTROSE IN WATER
- IV FLUID FOR METABOLIC PATIENT
- 0.9% SODIUM CHLORIDE 10% GLUCOSE 500ML BAG
- 0.45% SODIUM CHLORIDE 10% GLUCOSE 500ML BAG
- 0.45% SODIUM CHLORIDE 5% GLUCOSE 500ML BAG
- 0.18% SODIUM CHLORIDE 10% GLUCOSE 500ML BAG
- REQUIREMENTS OF RAW MATERIALS
- TABLE I: REQUIREMENT FOR DEXTROSE MONOHYDRATE
- INTRAVENOUS FLUID COMPOSITION
- CRYSTALLOIDS
- DEXTROSE
- NORMAL SALINE
- HARTMANN’S SOLUTION
- COLLOIDS
- IV BAGS MARKET
- MEDICAL FLUID BAG MARKET
- COVID-19 IMPACT
- MEDICAL FLUID BAGS MARKET SHARE
- SOURCE OF MACHINES TECHNOLOGY
- USES AND APPLICATION
- SOME GENERAL INTRAVENOUS FLUIDS
- SPECIFICATION OF INDIAN PHARMACOPEIA ON I.V FLUIDS DEXTRAN INJECTION
- DEXTRAN 110 INJECTIONS
- SODIUM CHLORIDE AND DEXTROSE INJECTION
- IDENTIFICATION:-
- ASSAY:
- BASIC RAW MATERIALS
- REQUIREMENTS OF RAW MATERIALS AND SPECIFICATIONS
- WATER FOR INJECTION
- HDPE PHARMA GRADE LAMINATE/ PLASTIC ROLL
- LABELING
- IDENTIFICATION
- HEAVY METALS
- COMPOSITION OF IV FLUID
- COMPOSITION OF COMMON IV FLUID (MEQ/L)
- COMPOSITION OF IV FLUIDS
- COMPOSITION OF COMMERCIAL I.V. FLUID AVAILABLE
- LARGE VOLUME PARENTERAL PREPARATION
- SOME EXAMPLES OF LVPS INCLUDE SOLUTIONS CONTAINING:
- ELECTROLYTE SOLUTIONS
- MILLIEQUIVALENT (MEQ)
- IN PLASMA;
- NOURISHING SOLUTIONS
- EXAMPLES:
- PLASMA EXPANDERS
- DEXTRANS:
- HUMAN SERUM ALBUMIN:
- PLASMA PROTEIN FRACTION:
- MANUFACTURING PROCESS FOR IV BAGS
- IT INVOLVES STEPS:-
- IV BAG PRODUCTION
- RAW MATERIAL SAMPLING AND DISPENSING
- THE PRODUCTION OF IV SOLUTION PRODUCTION LINE CONSISTS OF FIVE MAIN PHASES:
- IV BAG PRODUCTION OPTIONS
- IV BAG SEMI AUTOMATIC MANUFACTURING PROCESS
- LABELLING
- IV BAG FULL AUTOMATIC MANUFACTURING PROCESS
- PRODUCTION PROCEDURE FOR PARENTERAL DRUGS
- THE MANUFACTURING OF PARENTERALS INVOLVES THE FOLLOWING STEPS;
- PRODUCTION FACILITIES AND CONTROLS:
- 1. CLEAN-UP AREA:
- 2. PREPARATION AREA:
- 3. ASEPTIC AREA:
- 4. QUARANTINE AREA:
- 5. FINISHING & PACKAGING AREA:
- CONTROLLED ENVIRONMENT REQUIRED FOR PARENTERAL PREPARATION:
- CLASSIFICATION OF CLEAN ROOMS:-
- ASEPTIC PROCESSING:-
- MANUFACTURING PROCESS OF I.V. FLUID (FFS TECHNOLOGY)
- A TYPICAL FFS PROCESS WORKS AS FOLLOWS:
- PROCESS FLOW DIAGRAM
- PROCESS IN DETAILS
- 1. DISTILLED WATER PREPARATION
- 2. SOLUTION PREPARATION
- 3. INJECTION BLOW MOULDING
- 4. MOULDING PROCESS
- 5. FILLING PROCESS
- 6. SEALING PROCESS
- 7. MOULD OPENING PROCESS
- FILTRATION AND FILLING:-
- STERILIZATION:-
- QUALITY CONTROL:-
- THE WHOLE PROCESS CONSISTS OF THE FOLLOWING STEPS:-
- SWOT ANALYSIS
- FORM FILL SEAL TECHNOLOGY
- 1. FORM-FILL-SEAL TECHNOLOGY:-
- 1.5 FILTRATION (MEMBRANE):-
- LIST OF MACHINERY IV BAG PRODUCTION FORM FILL AND SEAL MACHINE
- IV BAG PRODUCTION (IV PRODUCTION AND PACKING)
- IV BAG EMPTY PRODUCTION LINE
- THE PRODUCTION OF I.V. SOLUTION PRODUCTION LINE CONSISTS OF 5 MAIN PHASES:
- 1. WATER PURIFYING
- 2. DISTILLATION
- 3. SOLUTION FILLING
- 4. STERILIZATION
- 5. PACKING
- A TYPICAL FFS PROCESS WORKS AS FOLLOWS.
- SUPPLIERS OF RAW MATERIALS
- SUPPLIERS OF POTASSIUM PERMANGANATE
- SUPPLIERS OF SODIUM CHLORIDE (I.P. GRADE)
- SUPPLIERS OF DEXTROSE
- ADDRESSES OF PLANT AND MACHINERY SUPPLIERS
- SUPPLIERS OF STERILIZING EQUIPMENTS
- SUPPLIERS OF PM METER
- SUPPLIERS OF LABELING MACHINES
- SUPPLIERS OF TANKS
- SUPPLIERS OF BOILER
- SUPPLIERS OF FILTER PRESS
- SUPPLIERS OF LABORATORY EQUIPMENTS
- SUPPLIERS OF MIXER
- EMPTY IV BAG MANUFACTURER AND SUPPLIER IN INDIA
- SUPPLIERS OF COMPLETE PLANT AND MACHINERY
- CONSULTANT OF TURNKEY PROJECT SUPPLIER OF THE PLANT AND MACHINERY
- CLEAN ROOM SUPPLIERS
Appendix
- 01. PLANT ECONOMICS
- 02. LAND & BUILDING
- 03. PLANT AND MACHINERY
- 04. OTHER FIXED ASSESTS
- 05. FIXED CAPITAL
- 06. RAW MATERIAL
- 07. SALARY AND WAGES
- 08. UTILITIES AND OVERHEADS
- 09. TOTAL WORKING CAPITAL
- 10. TOTAL CAPITAL INVESTMENT
- 11. COST OF PRODUCTION
- 12. TURN OVER/ANNUM
- 13. BREAK EVEN POINT
- 14. RESOURCES FOR FINANCE
- 15. INSTALMENT PAYABLE IN 5 YEARS
- 16. DEPRECIATION CHART FOR 5 YEARS
- 17. PROFIT ANALYSIS FOR 5 YEARS
- 18. PROJECTED BALANCE SHEET FOR (5 YEARS)
Frequently Asked Questions
Intravenous fluids are used to restore body fluids, maintain hydration, and correct electrolyte imbalances. They are administered directly into the bloodstream when patients cannot take sufficient fluids orally or require rapid fluid replacement due to dehydration, blood loss, illness, surgery, or other medical conditions. Depending on the formulation, IV fluids may also provide glucose for energy and support normal physiological functions during treatment.
The main types of IV fluids are crystalloids, colloids, free water solutions, and blood products. Crystalloids contain salts or electrolytes and are widely used for hydration and electrolyte replacement. Colloids contain larger molecules that help expand plasma volume. Free water solutions such as dextrose in water provide hydration and carbohydrates, while blood products are used in specialized clinical situations requiring blood component replacement.
Dextrose and sodium chloride solutions are commonly used because they provide both fluid replacement and essential nutrients or electrolytes. Dextrose supplies a readily available source of energy, while sodium chloride helps maintain electrolyte balance and fluid distribution within the body. Their combination makes them suitable for a wide range of medical conditions requiring intravenous therapy.
The manufacturing of IV fluids involves water purification, solution preparation, filtration, filling, sealing, sterilization, quality control, and packaging. These operations are performed in controlled clean-room environments to maintain sterility and product quality. Technologies such as Form-Fill-Seal (FFS) systems are commonly used to integrate container formation, filling, and sealing into a continuous production process.
Sterile manufacturing is essential because IV fluids are administered directly into the bloodstream. Production must therefore minimize contamination risks through clean-room facilities, aseptic processing, validated sterilization methods, and rigorous quality control. Maintaining sterility helps ensure patient safety, regulatory compliance, and consistent product quality throughout manufacturing and packaging.
Key considerations include production capacity, plant layout, clean-room infrastructure, water-for-injection systems, specialized machinery, raw material quality, sterilization equipment, packaging systems, and quality assurance processes. Financial planning, regulatory compliance, utilities, and reliable equipment suppliers are also important to establish an efficient and compliant manufacturing facility.
Why Choose Us
- More than 45 years of experience
- Managed by expert industrial consultants
- ISO 9001-2015 Certified
- Registered under MSME, UAM No: DL01E0012000
How We Work
- 24/5 Research Support Get your queries resolved from an industry expert. Ask before you purchase.
- Custom Research Service Speak to our consultants to design an exclusive study for your needs.
- Quality Assurance All reports are prepared by qualified consultants & verified by experts.
- Information Security Your personal & confidential information is always safe and secure.
Detailed Project Report (DPR) includes Present Market Position and Expected Future Demand, Technology, Manufacturing Process, Investment Opportunity, Plant Economics and Project Financials. comprehensive analysis from industry covering detailed reporting and evaluates the position of the industry by providing insights to the SWOT analysis of the industry.
Each report include Plant Capacity, requirement of Land & Building, Plant & Machinery, Flow Sheet Diagram, Raw Materials detail with suppliers list, Total Capital Investment along with detailed calculation on Rate of Return, Break-Even Analysis and Profitability Analysis. The report also provides a birds eye view of the global industry with details on projected market size and then progresses to evaluate the industry in detail.
We can prepare detailed project report on any industry as per your requirement.
We can also modify the project capacity and project cost as per your requirement. If you are planning to start a business, contact us today.
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Key highlights
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge over major competitors
- An array of graphics, BEP analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth with an impact-analysis
- A clear understanding of the competitive landscape and key product segments
- Ask for FREE project related details with our consultant/industry expert.
- Share your specific research requirements for customized project report.
- Request for due diligence and consumer centric studies.
- Still haven't found what you're looking for? Speak to our Custom Research Team.
EIRI Board is a single destination for all the industry, company and country reports. We feature a large repository of latest industry reports, leading and niche company profiles, and market statistics prepared by highly qualified consultants and verified by a panel of experts.
Note: We can also prepare project report on any subject based on your requirement and country. If you need, we can modify the project capacity and project cost based on your requirement.
Our reports provide an expansive market analysis of the sector by covering areas like growth drivers, trends prevailing in the industry as well as comprehensive SWOT analysis of the sector.
Our Clients
- Our research reports comprehensively cover Indian markets (can be modified as per your country), present investigation, standpoint and gauge for a time of five years*.
- The market conjectures are produced on the premise of optional research and are cross-accepted through associations with the business players.
- We use dependable wellsprings of data and databases, and data from such sources is handled by us and incorporated into the report.
- Our project reports include detailed analysis that helps get the industry's Present Market Position and Expected Future Demand.
- Offer real analysis driving variables for the business and the most recent business sector patterns in the industry.
- This report comprehends the present status of the business by clarifying a complete SWOT examination and investigation of the interest-supply circumstance.
- Report gives analysis and in-depth financial comparison of real players/competitors.
- The report gives estimates of key parameters which forecast business execution.
